Experts dedicated to prioritizing, designing, and executing clinical research that will reduce the public health threat of antibacterial resistance.
- Tweets 967
- Following 355
- Followers 1,216
- Likes 1,366
ALT A R L G Innovative Research Tools & Methods, arlg.org/tools-methods, A R L G logo, Antibacterial Resistance Leadership Group
ALT A R L G, Antibacterial Resistance Leadership Group, arlg.org, June 2026 Newsletter
ALT A R L G Grand Rounds Innovations in Diagnostic Trials Monday, June 8 | 4-5 p.m. ET Michael Satlin, MD, Weill Cornell Medicine Sarah Doernberg, MD, MAS, UC San Francisco Ritu Banerjee, MD, PhD Vanderbilt University Moderator: Robin Patel, MD, D(ABMM), FIDSA, FACP, F(AAM), FAAAS, Mayo Clinic A R L G: Antibacterial Resistance Leadership Group
ALT Summary of Results SCOUT CAP Short Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children ARLG Antibacterial Resistance Leadership Group
ALT Summary of Results CRACKLE-2 Consortium on Resistance Against Carbapenems in Klebsiella pneumoniae and other Enterobacteriaceae ARLG Antibacterial Resistance Leadership Group
ALT Desirability of Outcome Ranking DOOR ARLG's innovative method to help doctors and researchers design, analyze, and interpret clinical trials ARLG Antibacterial Resistance Leadership Group
ALT Summary of Results STAR Short-course Therapy and the Antibiotic Resistome ARLG Antibacterial Resistance Leadership Group
ALT Summary of Results Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) Combination regimen of Ceftazidime-Avibactam with Aztreonam Hollow Fiber Infection Model against NDM-1-producing Enterobacteriaceae (COMBINE HFIM) ARLG Antibacterial Resistance Leadership Group
ALT Study Milestone: Manuscript in Progress STEP FMT: Strain Temporal Engraftment and Persistence after Fecal Microbiota Transplantation Ahmed Babiker, MBBS, MSc Assistant Professor, Department of Internal Medicine, Division of Infectious Diseases, Rush University ARLG Early Faculty Seedling Award Recipient
ALT Study Milestone - Manuscript Submitted FAST: Fast Antibiotic Susceptibility Testing for gram-negative bacteremia ARLG: Antibacterial Resistance Leadership Group
ALT Manuscript published in Antimicrobial Agents and Chemotherapy, "A patient-centric paradigm and tool for clinical research: the DOOR is open" Hamasaki T, He Y, Wu Q, et al.
ALT Study Milestone: Manuscript Submitted DIFFR: Clostridioides DIFFicile RNA Sixto Manuel Leal Jr, MD, PhD Director, Clinical Microbiology Laboratory ARLG Early Stage Investigator Award Recipient ARLG: Antibacterial Resistance Leadership Group
ALT ESCMID Postgraduate Course - Clinical trials in infectious diseases: from generating the initial idea to reporting final results and everything in between ARLG: Antibacterial Resistance Leadership Group arlg.org
ALT Manuscript published in Clinical Microbiology and Infection, "Clinical Adjudication Approach for Rapid Diagnostics Aiming to Identify Bacteria Directly from Blood" Doernberg SB, Komarow L, Greenwood-Quaintance K, et al.
ALT ARLG: Antibacterial Resistance Leadership Group Member Spotlight A portrait of Heather R. Cross, DPhil, FAHA, RAC, Director of the ARLG Clinical Operations Center & Associate Director of the ARLG Scientific Leadership Center
ALT Study Milestone: Data Analysis ESCAPED: Emerging Staphylococcus aureus and Current Antimicrobial Patterns in Emergency Departments Jesus R. Torres, MD, MPH, MSc, FACEP Assistant Professor - UCLA Department of Emergency Medicine at David Geffen School of Medicine ARLG Early Stage Investigator Award Recipient
ALT Manuscript Published in Microbiology Resource Announcements, "Isolation and Genomic Analysis of Seven Phages Active Against Carbapenem-Resistant Klebsiella pneumoniae," Cuello L, Parmar K, Supandy A, Van Tyne D, Patel R, ARLG: Antibacterial Resistance Leadership Group
ALT ARLG Grand Rounds: The Why and How of the ACORN Trial Edward Qian, MD, MSACI, Todd W Rice, MD, MSc, Moderator: Sarah Doernberg, MD, MAS, FIDSA, ARLG: Antibacterial Resistance Leadership Group, arlg.org